CALIÒ, Anna
 Distribuzione geografica
Continente #
NA - Nord America 3.037
EU - Europa 2.562
AS - Asia 2.256
SA - Sud America 391
AF - Africa 46
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.305
Nazione #
US - Stati Uniti d'America 2.982
SG - Singapore 901
GB - Regno Unito 759
CN - Cina 744
IT - Italia 356
HK - Hong Kong 336
BR - Brasile 327
SE - Svezia 255
RU - Federazione Russa 246
DE - Germania 243
IE - Irlanda 217
FR - Francia 188
FI - Finlandia 118
KR - Corea 71
VN - Vietnam 57
UA - Ucraina 39
CA - Canada 33
NL - Olanda 28
BE - Belgio 26
AR - Argentina 23
TG - Togo 21
JP - Giappone 20
ES - Italia 17
IQ - Iraq 17
PL - Polonia 16
AT - Austria 15
IN - India 15
MX - Messico 14
TR - Turchia 14
EC - Ecuador 12
CO - Colombia 10
BD - Bangladesh 9
ID - Indonesia 9
SA - Arabia Saudita 9
AU - Australia 8
LT - Lituania 7
MA - Marocco 7
CH - Svizzera 6
IR - Iran 6
VE - Venezuela 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
IL - Israele 5
PY - Paraguay 5
CZ - Repubblica Ceca 4
TN - Tunisia 4
TW - Taiwan 4
CL - Cile 3
JM - Giamaica 3
MK - Macedonia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PK - Pakistan 3
BG - Bulgaria 2
CM - Camerun 2
DK - Danimarca 2
GR - Grecia 2
HU - Ungheria 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
SN - Senegal 2
UZ - Uzbekistan 2
AI - Anguilla 1
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
ML - Mali 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TV - Tuvalu 1
Totale 8.304
Città #
Southend 688
Dallas 533
Singapore 430
Chandler 416
Hong Kong 327
Dublin 215
Ashburn 181
Woodbridge 159
Jacksonville 148
Beijing 143
Ann Arbor 138
Munich 87
The Dalles 76
Verona 72
Lawrence 68
Princeton 68
Wilmington 67
New York 62
Jinan 59
Houston 54
Helsinki 47
Shenyang 46
Columbus 44
Redmond 42
Hebei 34
Nanjing 33
Santa Clara 31
Sindelfingen 31
Los Angeles 30
Tianjin 30
São Paulo 29
Milan 28
Ningbo 26
Seattle 26
Rome 25
Turku 25
Bologna 24
Changsha 23
Redwood City 22
Brussels 21
Lomé 21
Hangzhou 19
Nuremberg 18
Zhengzhou 18
Lancaster 17
Taizhou 17
Tokyo 16
Nanchang 14
San Francisco 14
Seoul 14
Brooklyn 13
Phoenix 13
Taiyuan 13
Chicago 12
Dearborn 12
Frankfurt am Main 12
Guangzhou 12
Ho Chi Minh City 12
Madrid 12
Moscow 12
Warsaw 12
London 11
Montreal 11
Rio de Janeiro 11
Amsterdam 10
Fairfield 10
Haikou 10
Hanoi 10
Norwalk 10
Belo Horizonte 9
Boardman 9
Boston 9
Chongqing 9
Pozza 9
Toronto 9
Shanghai 8
Washington 8
Bergamo 7
Brasília 7
Dong Ket 7
Falls Church 7
Fuzhou 7
Guayaquil 7
Jiaxing 7
Lappeenranta 7
San Donà Di Piave 7
Vienna 7
Baghdad 6
Council Bluffs 6
Jakarta 6
Johannesburg 6
Kent 6
Mexico City 6
Salvador 6
Ankara 5
Baku 5
Bauru 5
Boydton 5
Campinas 5
Chennai 5
Totale 5.206
Nome #
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 178
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis 168
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 168
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 160
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 151
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 147
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 146
Pancolitis with ischemic injury as a complication of immunosuppressive treatment in a patient with autoimmune hepatitis: a case report. 144
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 143
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 143
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 141
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 135
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 133
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 127
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 126
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 121
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 120
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 113
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 112
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation 109
Increased Frequency of Bronchiolar Histotypes in Lung Carcinomas Associated with Idiopathic Pulmonary Fibrosis 109
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 108
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis 104
Primary Seminal Vesicle Carcinoma. The Usefulness of Pax8 Immunohistochemical Expression for the Differential Diagnosis 103
Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases 103
Cathepsin K expression in clear cell "sugar" tumor (PEComa) of the lung 101
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 101
A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss 100
Multifocal Hepatic Angiosarcoma with Atypical Presentation: Case Report and Literature Review 95
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 95
Histology and immunohistochemical evaluation of phimotic prepuce: The role of steroid therapy 94
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 93
From fine-needle aspiration cytology to fluorescent in-situ hybridization in an unusual case of pharyngeal synovial sarcoma 91
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 91
MiT family translocation renal cell carcinoma: looking for diagnostic and druggable markers 90
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 88
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 88
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 87
Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer? 85
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 84
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 84
Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma 83
Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys 83
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 83
Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens 82
2022-RA-1535-ESGO Uterine PEComa and prognostic value of the proposed classification systems: a retrospective study, systematic review, and metanalysis 81
High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment 81
Recurrent primary endobronchial fetal rhabdomyoma: a case report and literature review 80
Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'? 79
Renomedullary Interstitial Cell Tumors: Pathologic Features and Clinical Correlations 79
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour 79
Intestinal-type primary vaginal adenocarcinoma. Review of the literature with report of a case: from diagnosis to management 78
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 77
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 76
Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation 74
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification 74
Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases 72
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 72
Interobserver Agreement in Immunohistochemical Evaluation of Folate Receptor Alpha (FRα) in Ovarian Cancer: A Multicentre Study 71
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey 71
Epithelioid angiomyolipoma: a pathological entity discovered in Verona with the endorsement of Doctor Rosai 71
Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press 69
VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations 69
Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma 67
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 66
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 65
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 64
Small renal masses in young adults: Insights from a large contemporary multi-institutional Registry 64
Well-differentiated neuroendocrine tumor of the urinary bladder expressing GATA 3 63
Determinants of oncologic outcomes in high-grade organ-confined prostate cancer after prostatectomy 62
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 61
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas 60
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022) 59
♂♀ Mixed Epithelial and Stromal Tumors of the Kidney 58
Papillary Adenomas and Other Small Epithelial Tumors in the Kidney: An Autopsy Study 58
Pathological features and clinical associations of 58 small incidental angiomyolipomas of the kidney. 57
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 52
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives 51
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma 49
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 48
Hot topics in renal cancer pathology: implications for clinical management 46
WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist 46
Identification of diagnostic and predictive morphological and molecular markers in renal tumors 45
Histology for nephrology, from pre-implantation to post-transplant kidney biopsy. Lesson learned from ReBIrth (Renal BIopsy for Kidney Transplantation Therapy) 44
Multitarget Fluorescence in Situ Hybridization diagnostic applications in solid and hematological tumors 43
HER2 Aberrations in NSCLC: So Close Yet So Far 42
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 42
Robot-assisted excision of hemangioma of the right renal vein 40
Patient Selection for Active Surveillance for Small Renal Masses: A Systematic Review of the Literature 39
Uterine perivascular epithelioid cell tumors (PEComa) and the accuracy of proposed classification systems in predicting the malignant versus non-malignant behavior 37
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 36
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice 35
Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centers 34
The World Health Organization 2022 Classification of renal tumors: key updates for urologists 33
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy 32
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est) 31
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 29
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data 29
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 29
Oncocytoma on renal mass biopsy: why is surgery even performed? 29
Totale 8.208
Categoria #
all - tutte 35.459
article - articoli 34.081
book - libri 0
conference - conferenze 787
curatela - curatele 0
other - altro 405
patent - brevetti 0
selected - selezionate 0
volume - volumi 186
Totale 70.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021467 0 0 34 81 73 79 29 19 18 31 67 36
2021/2022598 65 151 3 69 29 26 17 37 20 14 42 125
2022/20231.260 80 134 105 220 99 330 19 65 130 21 33 24
2023/2024786 35 55 73 73 88 127 42 54 22 48 122 47
2024/20252.415 124 136 185 319 93 76 128 96 313 231 268 446
2025/20261.394 508 451 435 0 0 0 0 0 0 0 0 0
Totale 8.588